Cerebral ischemic damage is prevalent and the second highest cause of death globally
across patient populations; it is as a substantial reason of morbidity and mortality …

Ischemic brain injury is associated with a high rate of mortality and disability with no effective
therapeutic strategy. Recently, a growing number of studies are focusing on mesenchymal …

Mesenchymal stromal cells (MSC) are a multipotent stem cell that can be derived from
several different tissues, including bone marrow. In preclinical studies, MSC have been …

Ischemic brain injury represents a major cause of death worldwide with limited treatment
options with a narrow therapeutic window. Accordingly, novel treatments that extend the …

Stroke is the most common neurological cause of morbidity and mortality in industrialized
countries, afflicting 15 million people every year. The numbers are expected to increase …

Stroke, the most prevalent cerebrovascular disease, causes serious loss of neurological
function and is the leading cause of morbidity and mortality worldwide. Despite advances in …

Stroke is a major cause of high mortality, morbidity and long-term disability worldwide.
Development of neuroprotective and neurorestorative therapies for stroke has been a target …

Cerebral ischemia is a common global disease that is characterized by a loss of
neurological function and a poor prognosis in many patients. However, only a limited …

Stroke continues to maintain its status as one of the top causes of mortality within the United
States. Currently, the only Food and Drug Administration (FDA)-approved drug in place for …

Stroke is the second cause of morbidity and mortality worldwide [1]. The reduced blood flow
generates ischemia area due to multiple processes such as excitotoxicity, ionic imbalance …